Bioresorbable Coronary Stents Market Analysis By Brand Outlook (Absorb BVS, Absorb 2nd Generation, Magmaris, Magnitude, MeRes-100, DESolve), By Region, And Segment Forecasts, 2016 - 2025
This report can be delivered to the clients within 48 Hrs
Anticipated as well as recently launched global bioresorbable coronary stents market will trigger a revenue increase to USD 247 million by 2025. According to a new report by Grand View Research, Inc., better device attributes of second-generation coronary stents will provide the ascending push to this market.
Bioresorbable stents are intended majorly for the young adult population, whereby these individuals are enabled with a normal functioning artery following complete resorption of the dissolvable devices.Lifestyle diseases and prevalence of associated risk factors underpin the growth in atherosclerosis-related cardiac events. This drives the global disease prevalence in young adults as well as the high volume of elective Percutaneous Coronary Interventions (PCI).
What sets the second-generation bioresorbable coronary stents apart? – Learning from past mistakes, manufacturers have developed new generation bioresorbable with thinner strut thicknesses, faster resorption times, and better radial force. Amaranth, with a single-minded focus on strut thickness, has developed three such devices. Each with a thinner strut. The latest, Magnitude boasts of 100 microns.
Another factor providing a fillip to this market is the less-invasive nature of PCIs as compared to coronary artery bypass grafting, resulting in their high elective procedure volume. In most parts of the world, lack of auditing to check inappropriate surgeries drives the number of coronary stenting procedures. Hence, this market is expected to witness growth due to the high volume of elective PCI, particularly in APAC and Europe.
Further Key Findings From the Study Suggest:
Anticipated as well as recently launched global bioresorbable coronary stents market will trigger a revenue increase to USD 247 million by 2025. According to a new report by Grand View Research, Inc., better device attributes of second-generation coronary stents will provide the ascending push to this market.
Bioresorbable stents are intended majorly for the young adult population, whereby these individuals are enabled with a normal functioning artery following complete resorption of the dissolvable devices.Lifestyle diseases and prevalence of associated risk factors underpin the growth in atherosclerosis-related cardiac events. This drives the global disease prevalence in young adults as well as the high volume of elective Percutaneous Coronary Interventions (PCI).
What sets the second-generation bioresorbable coronary stents apart? – Learning from past mistakes, manufacturers have developed new generation bioresorbable with thinner strut thicknesses, faster resorption times, and better radial force. Amaranth, with a single-minded focus on strut thickness, has developed three such devices. Each with a thinner strut. The latest, Magnitude boasts of 100 microns.
Another factor providing a fillip to this market is the less-invasive nature of PCIs as compared to coronary artery bypass grafting, resulting in their high elective procedure volume. In most parts of the world, lack of auditing to check inappropriate surgeries drives the number of coronary stenting procedures. Hence, this market is expected to witness growth due to the high volume of elective PCI, particularly in APAC and Europe.
Further Key Findings From the Study Suggest:
- Europe region is the major contributor for the bioresorbable stents market in 2016. Subsequent to withdrawal of the bioresorbable Absorb BVS, emergence of CE-approved bioresorbable stents hold strong growth prospects for greater sales in the member countries.
- APAC follows Europe with almost 30% segment share and is expected to record the fastest growth in the future
- Absorb BVS, among the key brands, engendered the highest sales revenue in 2016, while Absorb 2nd generation device will supersede the sales of its rival devices toward the end of the forecast period
- North America trails behind as the smallest revenue generator against leading counterparts, Europe and APAC, in this market. Downfall of Abbott’s Absorb BVS, the only approved FDA device, is the underlying reason for the small segment share in the U.S. region.
- Key players in this space include BIOTRONIK, Meril Lifesciences Pvt. Ltd., Abbott, Elixir Medical Corporation, REVA Medical, Arterial Remodeling Technologies, and Amaranth Medical
- Strategic efforts undertaken by the companies to gain a higher market share center on bioresorbable coronary stents development. Companies targeting the clinical pipeline have developed second-generation bioresorbable products with better design specifications, such as devices with thinner strut thicknesses and faster absorption rates that gain comparability with the gold standard, drug-eluting metallic stents.
CHAPTER 1 RESEARCH METHODOLOGY & SCOPE
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Research Methodology
1.3 Geographic Scope & Assumptions
1.4 Region-wise market calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based Segment Share Calculation
1.6 List of Secondary Sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 BIORESORBABLE CORONARY STENTS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 High disease prevalence in young adults
3.1.1.2 High Elective PCI Volume
3.1.2 Market restraint analysis
3.1.2.1 Slow pace of the market: Lack of adequate clinical trial results
3.1.2.2 Low comparability of bioresorbable coronary stents to DES
3.2 Penetration & Growth Prospect Mapping
3.3 Bioresorbable Coronary Stents Market- SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis - Porter’s
CHAPTER 4 BIORESORBABLE CORONARY STENTS MARKET: BRAND OUTLOOK, ESTIMATES & TREND ANALYSIS
4.1 Bioresorbable Coronary Stents Market: Brand analysis
4.2 Bioresorbable Coronary Stents Market: Brand movement analysis
4.2.1 Absorb BVS, 2016 - 2025 (USD Million)
4.2.2 Absorb 2nd Generation, 2016 - 2025 (USD Million)
4.2.3 Magmaris, 2016 - 2025 (USD Million)
4.2.4 Magnitude, 2016 - 2025 (USD Million)
4.2.5 MeRes-100, 2016 - 2025 (USD Million)
4.2.6 DESolve, 2016 - 2025 (USD Million)
CHAPTER 5 BIORESORBABLE CORONARY STENTS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
5.1 Bioresorbable Coronary Stents Market share, by region, 2016 & 2024
5.2 North America
5.2.1 North America Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.2.3 Canada
5.2.3.1 Canada Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.3 Europe
5.3.1 Europe Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.3.2 UK
5.3.2.1 UK Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.3.3 Germany
5.3.3.1 Germany Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.3.4 France
5.3.4.1 France Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.3.5 Italy
5.3.5.1 Italy Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.3.6 Spain
5.3.6.1 Spain Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.4.2 Japan
5.4.2.1 Japan Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.4.3 India
5.4.3.1 India Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
CHAPTER 6 COMPETITIVE LANDSCAPE
6.1 Strategy Framework
6.2 Market Participation Categorization
6.3 Company Profiles
6.3.1 Biotronik
6.3.1.1 Company overview
6.3.1.2 Product overview
6.3.1.3 Business Strategies
6.3.2 Meril Lifesciences Pvt. Ltd.
6.3.2.1 Company overview
6.3.2.2 Product overview
6.3.2.3 Business Strategies
6.3.3 Abbott
6.3.3.1 Company overview
6.3.3.2 Product overview
6.3.3.3 Business Strategies
6.3.4 Elixir Medical Corporation
6.3.4.1 Company overview
6.3.4.2 Product overview
6.3.4.3 Business Strategies
6.3.5 REVA Medical
6.3.5.1 Company overview
6.3.5.2 Product overview
6.3.5.3 Business Strategies
6.3.6 Arterial Remodeling Technologies
6.3.6.1 Company overview
6.3.6.2 Product overview
6.3.6.3 Business Strategies
CHAPTER 7 CLINICAL PIPELINE OVERVIEW
7.1 Amaranth Medical
7.1.1 Company overview
7.1.2 Pipeline products
7.1.3 Clinical Trials
7.2 Microport Scientific Corporation
7.2.1 Company overview
7.2.2 Pipeline products
7.2.3 Clinical Trials
7.3 Arterius
7.3.1 Company overview
7.3.2 Pipeline Products
7.3.3 Clinical Trials
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Research Methodology
1.3 Geographic Scope & Assumptions
1.4 Region-wise market calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based Segment Share Calculation
1.6 List of Secondary Sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 BIORESORBABLE CORONARY STENTS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 High disease prevalence in young adults
3.1.1.2 High Elective PCI Volume
3.1.2 Market restraint analysis
3.1.2.1 Slow pace of the market: Lack of adequate clinical trial results
3.1.2.2 Low comparability of bioresorbable coronary stents to DES
3.2 Penetration & Growth Prospect Mapping
3.3 Bioresorbable Coronary Stents Market- SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis - Porter’s
CHAPTER 4 BIORESORBABLE CORONARY STENTS MARKET: BRAND OUTLOOK, ESTIMATES & TREND ANALYSIS
4.1 Bioresorbable Coronary Stents Market: Brand analysis
4.2 Bioresorbable Coronary Stents Market: Brand movement analysis
4.2.1 Absorb BVS, 2016 - 2025 (USD Million)
4.2.2 Absorb 2nd Generation, 2016 - 2025 (USD Million)
4.2.3 Magmaris, 2016 - 2025 (USD Million)
4.2.4 Magnitude, 2016 - 2025 (USD Million)
4.2.5 MeRes-100, 2016 - 2025 (USD Million)
4.2.6 DESolve, 2016 - 2025 (USD Million)
CHAPTER 5 BIORESORBABLE CORONARY STENTS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
5.1 Bioresorbable Coronary Stents Market share, by region, 2016 & 2024
5.2 North America
5.2.1 North America Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.2.3 Canada
5.2.3.1 Canada Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.3 Europe
5.3.1 Europe Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.3.2 UK
5.3.2.1 UK Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.3.3 Germany
5.3.3.1 Germany Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.3.4 France
5.3.4.1 France Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.3.5 Italy
5.3.5.1 Italy Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.3.6 Spain
5.3.6.1 Spain Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.4.2 Japan
5.4.2.1 Japan Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
5.4.3 India
5.4.3.1 India Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
CHAPTER 6 COMPETITIVE LANDSCAPE
6.1 Strategy Framework
6.2 Market Participation Categorization
6.3 Company Profiles
6.3.1 Biotronik
6.3.1.1 Company overview
6.3.1.2 Product overview
6.3.1.3 Business Strategies
6.3.2 Meril Lifesciences Pvt. Ltd.
6.3.2.1 Company overview
6.3.2.2 Product overview
6.3.2.3 Business Strategies
6.3.3 Abbott
6.3.3.1 Company overview
6.3.3.2 Product overview
6.3.3.3 Business Strategies
6.3.4 Elixir Medical Corporation
6.3.4.1 Company overview
6.3.4.2 Product overview
6.3.4.3 Business Strategies
6.3.5 REVA Medical
6.3.5.1 Company overview
6.3.5.2 Product overview
6.3.5.3 Business Strategies
6.3.6 Arterial Remodeling Technologies
6.3.6.1 Company overview
6.3.6.2 Product overview
6.3.6.3 Business Strategies
CHAPTER 7 CLINICAL PIPELINE OVERVIEW
7.1 Amaranth Medical
7.1.1 Company overview
7.1.2 Pipeline products
7.1.3 Clinical Trials
7.2 Microport Scientific Corporation
7.2.1 Company overview
7.2.2 Pipeline products
7.2.3 Clinical Trials
7.3 Arterius
7.3.1 Company overview
7.3.2 Pipeline Products
7.3.3 Clinical Trials
LIST OF TABLES
Table 1 Country share estimation
Table 2 North America bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
Table 3 U.S bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
Table 4 Canada bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
Table 5 Europe bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
Table 6 UK bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
Table 7 Germany bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
Table 8 Asia Pacific bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
Table 9 Japan bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
Table 10 India bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
Table 11 List of Market Players
Table 1 Country share estimation
Table 2 North America bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
Table 3 U.S bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
Table 4 Canada bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
Table 5 Europe bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
Table 6 UK bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
Table 7 Germany bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
Table 8 Asia Pacific bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
Table 9 Japan bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
Table 10 India bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
Table 11 List of Market Players
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Value chain-based sizing & forecasting
Fig. 4 QFD modeling for market share assessment
Fig. 5 Market summary
Fig. 6 Market trends & outlook
Fig. 7 Market segmentation & scope
Fig. 8 Market driver relevance analysis (Current & future impact)
Fig. 9 Global percentage of stroke occurrence, by age group
Fig. 10 Market restraint relevance analysis (Current & future impact)
Fig. 11 Penetration & growth prospect mapping
Fig. 12 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Bioresorbable coronary stents market type outlook: key takeaways
Fig. 15 Bioresorbable coronary stents market: Type movement analysis
Fig. 16 Brand Outlook, 2016 - 2025 (USD Million)
Fig. 17 Regional market place: Key takeaways
Fig. 18 Regional outlook, 2016 & 2024
Fig. 19 North America bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 20 U.S. bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 21 Canada bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 22 Europe bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 23 UK bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 24 Germany bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 25 France bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 26 Italy bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 27 Spain bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 28 Asia Pacific bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 29 Japan bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 30 India bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 31 Strategy framework
Fig. 32 Participant categorization
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Value chain-based sizing & forecasting
Fig. 4 QFD modeling for market share assessment
Fig. 5 Market summary
Fig. 6 Market trends & outlook
Fig. 7 Market segmentation & scope
Fig. 8 Market driver relevance analysis (Current & future impact)
Fig. 9 Global percentage of stroke occurrence, by age group
Fig. 10 Market restraint relevance analysis (Current & future impact)
Fig. 11 Penetration & growth prospect mapping
Fig. 12 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Bioresorbable coronary stents market type outlook: key takeaways
Fig. 15 Bioresorbable coronary stents market: Type movement analysis
Fig. 16 Brand Outlook, 2016 - 2025 (USD Million)
Fig. 17 Regional market place: Key takeaways
Fig. 18 Regional outlook, 2016 & 2024
Fig. 19 North America bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 20 U.S. bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 21 Canada bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 22 Europe bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 23 UK bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 24 Germany bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 25 France bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 26 Italy bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 27 Spain bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 28 Asia Pacific bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 29 Japan bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 30 India bioresorbable coronary stents market, 2016 - 2025 (USD Million)
Fig. 31 Strategy framework
Fig. 32 Participant categorization
